Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patients
- PMID: 39643005
- DOI: 10.1016/j.ajt.2024.11.029
Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patients
Keywords: HLA-incompatible transplantation; crossmatch-positive transplantation; desensitization; long-term outcomes.
Conflict of interest statement
Declaration of competing interest The authors of this manuscript have conflicts of interest to disclose as described by American Journal of Transplantation. A.Q. Maldonado, K. Sjöholm, A. Lagergren, A. Runström, J. Tollemar, and P. Lefèvre reports employment and equity or stocks from the Hansa Biopharma AB. S.C. Jordan, R.A. Montgomery, and T. Lundgren reports a consulting or advisory, funding grants, speaking and lecture fees, and travel reimbursement from the Hansa Biopharma AB. B.E. Lonze, N.M. Desai, C. Legendre, B.v.Z. Mühlen, and A.A. Vo reports funding grants from the Hansa Biopharma AB.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials